Pharmanutra SpA – Lobbying Governance & Transparency

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Lobbying Governance

Overall Assessment	Analysis	Score
None	Pharmanutra SpA has strengthened its sustainability oversight by expanding its Audit and Risk Committee into an “Audit, Risk and Sustainability Committee” tasked with “examining and evaluating sustainability issues” and by assigning an “Executive Director of specific delegated powers for the management of the organisation's impacts on economy, the environment and people” alongside an ESG Manager to monitor sustainability KPIs; however, the company does not disclose any governance process for lobbying. We found no evidence of procedures, responsible bodies or individuals overseeing the alignment of direct lobbying activities or indirect lobbying through trade associations, nor any process to ensure that the company’s policy advocacy aligns with its sustainability or climate objectives. View Sources	E

Overall Assessment

Analysis

Score

None

Pharmanutra SpA has strengthened its sustainability oversight by expanding its Audit and Risk Committee into an “Audit, Risk and Sustainability Committee” tasked with “examining and evaluating sustainability issues” and by assigning an “Executive Director of specific delegated powers for the management of the organisation's impacts on economy, the environment and people” alongside an ESG Manager to monitor sustainability KPIs; however, the company does not disclose any governance process for lobbying. We found no evidence of procedures, responsible bodies or individuals overseeing the alignment of direct lobbying activities or indirect lobbying through trade associations, nor any process to ensure that the company’s policy advocacy aligns with its sustainability or climate objectives.

View Sources

Lobbying Transparency

Overall Assessment	Analysis	Score
None	No evidence found	E